1‐Aryl‐6,7‐Dimethoxy‐3,4‐Dihydroisoquinoline‐2(1 H )‐Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity
ChemMedChem · 29.07.2026 · 21 (14)
DOI: 10.1002/cmdc.70390 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 23.07.2026. Verfasst von Federico Ricci und 8 weiteren Autor:innen. Beteiligte Einrichtung: CHIBIOFARAM Department, University of Messina, Messina, Italy. Hauptthemen laut MEDLINE: Sulfonamides, Carbonic Anhydrase Inhibitors, Carbonic Anhydrases, Isoquinolines. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca.
Abstract (Originalsprache)
Human carbonic anhydrase XII (hCA XII) represents an important pharmacological target for different types of cancer. hCA XII plays a crucial role in regulating both extracellular and intracellular pH, thereby influencing cancer cell proliferation, invasion, growth, and metastasis. Although the interaction features of hCA inhibitors (hCAIs) with the catalytic site of distinct hCA isoforms are generally well described, the lack of selectivity remains a major challenge. In a previous work, we have reported a series of 1‐aryl‐6,7‐dimethoxy‐3,4‐dihydroisoquinoline‐2(1 H )‐sulfonamides displaying weak activity against the ubiquitous hCA I and hCA II, thus emerging as hCAIs that may be free of unwanted side‐effects. Herein, further evaluation of their CA inhibitory effects allowed to disclose three potent hCA XII inhibitors at low nanomolar concentrations ( K i values ranging from 5.5 to 6.5 nM). Additionally, they showed remarkable isoform selectivity compared with the well‐known inhibitor SLC‐0111, currently in clinical trials as an antitumor agent. Crystallography analyses and computational studies clarified the molecular basis of this behavior and provided valuable insights for the rational design of selective inhibitors targeting hCA XII.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHIBIOFARAM Department, University of Messina, Messina, Italy.
- Institute of Biostructures and Bioimaging, CNR, Napoli, Italy.
- NEUROFARBA Department, University of Florence, Sesto Fiorentino, Florence, Italy.
ORCID-Profile: Andrea Angeli, Claudiu T Supuran, Rosaria Gitto
Förderung
- Ministero dell'Istruzione, dell'Università e della Ricerca
Zitieren
APA
Ricci, F., Di Fiore, A., Angeli, A., De Luca, L., Mancuso, F., Esposito, D., De Simone, G., Supuran, C. T., & Gitto, R. (2026). 1‐Aryl‐6,7‐Dimethoxy‐3,4‐Dihydroisoquinoline‐2(1 H )‐Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity. ChemMedChem, 21(14). https://doi.org/10.1002/cmdc.70390
Vancouver
Ricci F, Di Fiore A, Angeli A, De Luca L, Mancuso F, Esposito D, et al. 1‐Aryl‐6,7‐Dimethoxy‐3,4‐Dihydroisoquinoline‐2(1 H )‐Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity. ChemMedChem. 2026;21(14). doi:10.1002/cmdc.70390
BibTeX
@article{Ricci2026,
author = {Ricci, Federico and Di Fiore, Anna and Angeli, Andrea and De Luca, Laura and Mancuso, Francesca and Esposito, Davide and De Simone, Giuseppina and Supuran, Claudiu T and Gitto, Rosaria},
title = {1‐Aryl‐6,7‐Dimethoxy‐3,4‐Dihydroisoquinoline‐2(1 H )‐Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {14},
doi = {10.1002/cmdc.70390}
}
EUVIMED